Bunkerhill Health today announced it has received U.S. Food and Drug Administration (FDA) clearance for ECG-EF, an artificial intelligence algorithm that detects reduced left ventricular ejection ...

The American Heart Association, a relentless force changing the future of health for everyone everywhere, is launching a new initiative to improve in-hospital care for people with heart failure with ...

The American Heart Association (AHA) launched a news initiative to address challenges with in-hospital care for patients with ...

Study reveals digoxin improves heart pump function and helps ease heart failure and atrial fibrillation symptoms.

One study examines the small molecular cardiac myosin inhibitor for safety and efficacy at 96 weeks, and another compares it ...

Funding supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar ...

Reduced left ventricular ejection fraction and an increased extent of obstructive coronary artery disease signal an elevated ...

The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...

Telehealth company Caregility, hybrid cancer care company Daymark Health and virtual care company AmplifyMD also garnered funding.

Recent headlines suggested that a common heart attack drug ‘doesn’t work’ and may be fatal for women. A cardiologist reviews the evidence.

On top of performing implantable cardioverter-defibrillator (ICD) functions, the integrated device also delivered appropriate ...

Conducted across seven U.S. health systems including Duke University Health System, Cleveland Clinic, and Ascension St. Vincent, VITAL-HF enrolled 178 adults with HFrEF who were not yet optimized on ...